Close Menu

private financing

The firm said it would use the funding to grow its client base and further R&D programs using machine learning for biomarker discovery and precision medicine.

The Wilmington, Delaware-based startup will use the funds for clinical validation trials on its Arna Breast cancer diagnostic test in the US and Europe. 

Hexagon's discovery platform is designed to identify potentially therapeutic secondary metabolites and their protein targets from fungal genomes.

The Tokyo-based firm is looking to expand into the US market following a recent ¥700 million ($6.6 million) Series B financing round.

The funding will allow the company to accelerate development of its DNA synthesis technology, hire staff, build an R&D facility, and establish industrial partnerships.

Horizons Ventures led the round, joined by Airbus Ventures, bringing the MIT spinout's fundraising total to date to more than $21 million.

he single-cell microbiome sequencing firm has raised a total of ¥1.5 billion in equity financing since its founding in 2018.

The financing will be used for the development and clinical validation of oncology panels for treatment selection and patient monitoring with an initial focus on NSCLC.

The South San Francisco-based firm will use the funding to scale its Tapestri single-cell multi-omics technology to pharma trials and for characterization for cell and gene therapies.

The money will be used for research and development, building a clinical laboratory network, and seeking regulatory approval.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.